liver transplantation. Liver transplant infection
Conditions
Interventions
Intervention 1: first Intervention group: Ampicillin-sulbactam(3 g every 6 hours) with Ceftizoxime (2 g every 8 hours). Intervention 2: Second Intervention group: Ampicillin-sulbactam(3 g every 6 hour
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients which candidate to liver transplant older than 18 years old
Exclusion criteria
Exclusion criteria: Positive history of allergic reactions to antibiotics which use in this study renal failure patients with hemo-dialysis serum creatinine levels more than 1.5 mg/dL,blood urea nitrogen (BUN) more than 25 mg/dL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of bacterial infections in the first month after liver transplantation. Timepoint: During first month after liver transplantation. Method of measurement: Centers for Disease Control and Prevention (CDC) definitions for nosocomial infections. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality rate in liver transplant patients. Timepoint: Duration of hospitalization. Method of measurement: By reviewing patient file information.;Length of intensive care unit stay. Timepoint: Duration of hospitalization. Method of measurement: By reviewing patient file information.;Length of hospital stay. Timepoint: Duration of hospitalization. Method of measurement: By reviewing patient file information. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMojtaba Shafiekhani
Shiraz University of Medical Sciences
Outcome results
None listed